podcast about glp 1 Serena Williams and Oprah on Deciding to Take GLP-1 Medications Bright Spots in Healthcare Podcast

But as the FDA giveth, the FDA taketh away , and companies in the compounded tirzepatide business are now confronting the reality of Lilly having pumped billions of dollars into its manufacturing capabilities and an urgent shareholder demand to recoup the profit

Your medications ship directly to your home with provider oversight

A serotonin 5-HT 2A receptor antagonist was shown to reduce neuronal proliferation, and chronic administration of a 5-HT 1A receptor agonist increased neuronal proliferation (Jha et al., 2008)

As these medications become increasingly prescribed beyond the diabetes indication, it is imperative to understand the effects of GLP-1 RAs on the cutaneous microenvironment and provide effective aesthetic treatments to counteract these changes

Understanding potential risks empowers you to make informed decisions